STERIS (NYSE:STE) Releases FY 2025 Earnings Guidance

STERIS (NYSE:STE) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 9.050-9.150 for the period, compared to the consensus earnings per share estimate of 9.060. The company issued revenue guidance of $5.4 billion-$5.4 billion, compared to the consensus revenue estimate of $5.5 billion.

Wall Street Analysts Forecast Growth

STE has been the topic of a number of research reports. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, November 8th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Monday, November 18th. Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Finally, Stephens reiterated an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus price target of $263.75.

STERIS Stock Performance

NYSE:STE traded up $1.57 during midday trading on Wednesday, reaching $220.97. The stock had a trading volume of 887,926 shares, compared to its average volume of 476,648. The firm has a fifty day simple moving average of $212.33 and a two-hundred day simple moving average of $224.59. STERIS has a 12-month low of $197.82 and a 12-month high of $248.24. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The stock has a market cap of $21.81 billion, a P/E ratio of 50.45 and a beta of 0.84.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.78% and a net margin of 8.02%. On average, equities analysts expect that STERIS will post 9.11 EPS for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s payout ratio is currently 52.05%.

Insider Transactions at STERIS

In related news, SVP Cary L. Majors sold 1,682 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.14% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.